Apotheek De Geyter

Active

Public limited companyfounded 1985active for 41 yearsHoogstraat 10, 9620 Zottegem, BelgiumKBO/BCE: BE 0427.043.290

From the official registers: KBO 41 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek De Geyter has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137,221 and a net result of €73,700. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 45% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

Apotheek De GeyterActiveChecked score 87/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 29-03-1985 Normal situation
Legal form: Public limited company
Registered office: Hoogstraat 10, 9620 Zottegem
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.026.826.381 9620 Zottegem, since 15-04-1985
Financial year end: 30 September
Peppol: Reachable since 08-07-2025

Company details

Board and ownership

Board

GeMu FarmaDirector · since 01-10-2020 · permanent representative Veerle De Geyter

Shareholders

GeMu Farma100%annual accounts 30-09-2025

Board & ownership

Financial position

87 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts to 30-09-2025

Gross margin: €144,490; ▼ 24.4%
Turnover: ≈ €670,000; estimated
Profit: €73,700; ▲ 10.9%
Equity: €137,221; ▲ 2.0%
Total assets: €432,080; ▼ 1.1%
Staff: 1.1 FTE; ▲ 10.0%

2025 accounts filed 36 days before the deadline

Filed on 25-03-2026PDF

Financials

Score breakdownraises riskSector: Retail trade (NACE 47)Size: 1.1 FTE, total assets €432,080lowers riskFounded in 1985Legal form: public limited companyShow the evidence

Checked score

Score 2025

87 / 100

Excellent

Probability in this band: under 0.55%

Financially stronger than 53% of micro companies in retail trade (NACE 47)

Every signal that counts is listed under Signals.

Financial strength · tick: 2024

Strong

Solvency 57+1

equity 31.8% of total assets

Liquidity 36+2

short-term debt 43.7% · cash 5.4%

Profitability 90+2

return on assets 17.1%

Bankruptcy probability within 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.3%▲ +0.1 percentage points vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025highest value 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.2%▼ -0.1 percentage points vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025lowest value 12-2025: 0.2%● unchanged vs 11-2025lowest value 01-2026: 0.3%▲ +0.1 percentage points vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.2%▼ -0.1 percentage points vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026

Credit of up to €11,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 2.16 (2.1 in 2024), above the usual 1.5. Short-term debt is 43.7% and cash 5.4% of total assets. However, 68.2% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 47% of them on solvency, 33% on liquidity, 85% on profitability and 45% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Retail trade (NACE 47)

KBO

Founded in 1985

Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.

KBO

Legal form: public limited company

KBO

Size: 1.1 FTE, total assets €432,080

Companies of this size fail more often. How much that weighs depends on the rest of the company's profile.

NBB · annual accounts

Growing equity

Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.

NBB · annual accounts 2025

Equity per financial year

19202122232425

2019 to 2025 · latest year €137,221

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 25-03-2026, 36 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

36 days early

2024

40 days early

2023

40 days early

2022

2 days early

2021

31 days early

2020

32 days early

2019

15 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 28 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 25 March (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end01-11-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Key points

Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
New directorlatest change 06-03-2026 · 1 in office 1 joined View
Positive: 5 profitable years in a rowprofit 2025: €73,700 5 years View

Documents

Key facts about Apotheek De Geyter

What is the company number of Apotheek De Geyter?: The company number of Apotheek De Geyter is 0427.043.290. The VAT number is the same number with BE in front: BE 0427.043.290.
Where is Apotheek De Geyter based?: The registered office is at Hoogstraat 10, 9620 Zottegem.Company details
What does Apotheek De Geyter do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Geyter?: The legal form of Apotheek De Geyter is Public limited company (NV).
When was Apotheek De Geyter founded?: Apotheek De Geyter was founded on 29-03-1985.
Is Apotheek De Geyter still active?: Yes, Apotheek De Geyter is an active enterprise in the KBO register.
How many employees does Apotheek De Geyter have?: Apotheek De Geyter had an average of 1.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek De Geyter?: The turnover in financial year 2025 is ≈ €670,000. This figure is estimated from the gross margin of €144,490 and 51 comparable companies (NACE 477). It probably lies between €460,000 and €1.3m.
Is Apotheek De Geyter profitable?: In financial year 2025, Apotheek De Geyter made a profit of €73,700.
Where can I find the annual accounts of Apotheek De Geyter?: Apotheek De Geyter filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek De Geyter due?: Apotheek De Geyter must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Companies linked to Apotheek De Geyter

Parent and group

GeMu Farma100%

Comparable companies

These companies have the same main activity as Apotheek De Geyter: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €367,000 and €542,000, founded between 1981 and 1989.

Company	Total assets	Gross margin
Apotheek De Geyter Zottegem	€432,080	€144,490
APOTEEK DIEPENDALE Oudenaarde	€504,088	€143,217
Apotheek Bresseleers-Van der Cruyce Buggenhout	€509,818	€132,124
Apotheek Lise-Marie Kinnaer Aalst	€367,043	€120,775
Apotheek Browaeys Kluisbergen	€541,697	€142,097
PHARMACIE D'AVROY Liège	€446,107	€129,770
Grote Markt Blankenberge	€398,982	€137,697